BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/26/2021 11:20:59 AM | Browse: 1197 | Download: 2367
Publication Name World Journal of Gastroenterology
Manuscript ID 61954
Country Argentina
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy
Manuscript Source Invited Manuscript
All Author List Alberto E Muñoz, Florencia D Pollarsky, Mónica Marino, Mariano Cartier, Horacio Vázquez, Pablo Salgado and Gustavo Romero
ORCID
Author(s) ORCID Number
Alberto E Muñoz http://orcid.org/0000-0002-5458-4692
Florencia D Pollarsky http://orcid.org/0000-0003-1882-6639
Mónica Marino http://orcid.org/0000-0002-1370-7916
Mariano Cartier http://orcid.org/0000-0003-1690-9377
Horacio Vázquez http://orcid.org/0000-0002-9641-3437
Pablo Salgado http://orcid.org/0000-0003-4232-7178
Gustavo Romero http://orcid.org/0000-0002-4100-2067
Funding Agency and Grant Number
Corresponding Author Alberto E Muñoz, MD, Assistant Professor, Manager, Attending Doctor, Medical Assistant, Staff Physician, Sección Hepatología, Hospital de Gastroenterología Dr. Carlos Bonorino Udaondo, Facultad de Medicina, Universidad de Buenos Aires, Av, Caseros 2061, Ciudad Autónoma de Buenos Aires 1264, Argentina. aemunoz@intramed.net
Key Words Cirrhosis; Liver disease; Statins; Safety; Efficiency
Core Tip Several observational studies of statins in patients with liver disease were published, but they were highly biased. On the other hand, only one randomized controlled trial (RCT) improved survival in Child-Pugh class A/B patients but did not reduce variceal rebleeding. Finally, the dose and type of statin to be used should be defined. This review concludes that news RCTs are necessary before endorsing statins use in patients with chronic liver disease.
Publish Date 2021-07-26 11:20
Citation Muñoz AE, Pollarsky FD, Marino M, Cartier M, Vázquez H, Salgado P, Romero G. Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy. World J Gastroenterol 2021; 27(28): 4639-4652
URL https://www.wjgnet.com/1007-9327/full/v27/i28/4639.htm
DOI https://dx.doi.org/10.3748/wjg.v27.i28.4639
Full Article (PDF) WJG-27-4639.pdf
Full Article (Word) WJG-27-4639.docx